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Abstract
Synthetic [2Fe-2S] clusters are often used to elucidate ligand effects on the reduction potentials 
and spectroscopy of natural electron transfer sites, which can have anionic Cys ligands or neutral 
His ligands. Current synthetic routes to [2Fe-2S] clusters are limited in their feasibility with a 
range of supporting ligands. Here we report a new synthetic route to synthetic [2Fe-2S] clusters, 
through oxidation of an iron(I) source with elemental sulfur. This method yields a neutral 
diketiminate-supported [2Fe-2S] cluster in the diiron(III) oxidized form. The oxidized [2Fe-2S] 
cluster can be reduced to a mixed valent iron(II)-iron(III) compound. Both the diferric and reduced 
mixed valent clusters are characterized using X-ray crystallography, Mössbauer spectroscopy, EPR 
spectroscopy and cyclic voltammetry. The reduced compound is particularly interesting because 
its X-ray crystal structure shows a difference in Fe-S bond lengths to one of the iron atoms, 
consistent with valence localization. The valence localization is also evident from Mössbauer 
spectroscopy.
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Introduction
Iron-sulfur clusters primarily function in electron transfer roles [1,2,3,4,5]. Their ability to 
accept and discharge electrons quickly is related to the small reorganization energy between 
redox states [6,7]. The [2Fe-2S] clusters typically cycle between an oxidized diferric state 
(2Fe3+) and a one electron reduced state (Fe2+Fe3+). Ferredoxin type [2Fe-2S] clusters are 
ligated by four cysteine residues, and Rieske type clusters have one iron ligated by two 
histidines (Figure 1) [8,9]. MitoNEET has a new type of [2Fe-2S] cluster, which is 
coordinated by three cysteines and one histidine (Figure 1) [10]. The influences of first- and 
second-sphere amino acid residues on the redox potentials of these clusters have been 
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In order to provide fundamental information on the properties of these clusters in the 
absence of the protein scaffold, synthetic chemists have prepared many [2Fe-2S] clusters [8]. 
Synthetic clusters help to elucidate how simpler ligands influence the reduction potentials 
and spectroscopic signatures, enabling the confident correlation of structure, spectroscopy, 
and behavior [16,17,18,19]. Traditionally, [2Fe-2S] clusters have been synthesized in two 
ways: cluster assembly or ligand exchange [8,20,21,22]. Cluster assembly entails the 
reaction between an iron(III) salt, a bidentate thiolate and NaSH. Addition of sulfur to a 
rubredoxin analogue, [Fe(SR)4]2−, also results in the self-assembly of a [2Fe-2S] cluster 
[23]. Ligand exchange is another method for accessing new [2Fe-2S] clusters, particularly 
for clusters that do not have S-based capping ligands. For example, synthetic [2Fe-2S] 
clusters with capping N ligands were synthesized using the reaction of [(Fe2S2Cl2)(NEt4)2] 
with a deprotonated ligand [16–19]. The resulting clusters have spectroscopic features 
similar to the biological clusters but have Fe3+2/Fe2+Fe3+ couples that are more negative by 
0.36 to 1.73 V [16–19,24,25,26,27]. So far, the N-donors in the synthetic compounds have 
been based on imidazolates and benzimidazolates, and the use of a wider range of donors 
has been difficult because of the limited number of methods for synthetic access. The 
development of new synthetic routes, particularly for N-donor ligands that help to 
understand Rieske and MitoNEET clusters, is of interest. For example, a new route to a 
[2Fe-2S] cluster is adding elemental sulfur and tetramethylthiourea (tmtu) to an iron amide 
complex [28].
Diketiminate ligands (for example, L = MeC[C(Me)N(2,6-Me2C6H3)]2) are well-established 
supporting groups for low coordinate iron chemistry [29], and we previously reported 
diiron(II) complexes with a single sulfide bridge [30,31]. However, synthesizing a 
diketiminate-supported [2Fe-2S] cluster is difficult. In our hands, the ligand exchange 
method forms L2Fe as the major product. In this contribution, we describe a method in 
which elemental sulfur oxidizes a transient iron(I) species to give a diferric [2Fe-2S] cluster. 
A similar synthesis of a [2Fe-2S] cluster from a diiron(I) species was recently published 
[32]. The monoanionic diketiminate ligand gives the overall cluster the same charge as 
Rieske clusters (Figure 1). We characterize both the oxidized (Fe3+2) and the rare reduced 
(Fe3+Fe2+) clusters, with an eye toward insight into the biological system.
Materials and Methods
Unless otherwise noted, all manipulations were performed under an inert atmosphere using 
Schlenk techniques or in an M. Braun N2-filled glovebox with O2 levels maintained at or 
below 1 ppm. All glassware was dried at 150 °C overnight and Celite was dried under 
vacuum at 200 °C overnight. All solvents, unless otherwise noted, were dried using activated 
alumina and copper columns and stored over 4 Å molecular sieves. Acetonitrile was stored 
under 3 Å molecular sieves. THF was dried by distillation from a Na/benzophenone still and 
stored over 4 Å molecular sieves. C6D6 was dried with alumina, vacuum transferred and 
stored over 4 Å molecular sieves. KC8 was prepared by heating graphite and elemental 
potassium at 160 °C for 4 hours under an argon atmosphere. [LFe(μ-Cl)]2 was synthesized 
via a previously published procedure [33]. PPNCl (bis(triphenylphosphine)iminium 
chloride) and cryptand-2.2.2 were purchased from Sigma Aldrich.
Reesbeck et al. Page 2













Synthesis of [LFe(μ-S)]2 (L = MeC[C(Me)N(2,6-Me2C6H6)]2)
Under an atmosphere of N2, [LFe(μ-Cl)]2 (360.1 mg, 0.438 mmol) was dissolved in THF 
(20 mL) to give a yellow solution and then cooled to −100 °C in a liquid nitrogen cold well. 
Potassium graphite (136.1 mg, 1.007 mmol, 2.299 equiv) was then added as a solid to the 
stirring solution. The yellow solution turned dark green upon addition. The reaction mixture 
was stirred for 30 s at −100 °C and then S8 (27.9 mg, 0.109 mmol, 0.249 equiv) was added. 
The reaction mixture was warmed to room temperature while stirring and stirred for 2 h at 
ambient temperature. The volatile materials were removed under reduced pressure to obtain 
a dark solid. This solid was then dissolved in dichloromethane (30 mL) and stirred for 10 
min at ambient temperature. The purple solution was then filtered through Celite, washing 
with additional dichloromethane (10 mL) until the filtrate ran clear. The solvent was 
removed under vacuum to provide a black solid. This solid was washed with pentane (10 
mL) and dried to give a black solid (291.4 mg, 0.358 mmol, 81.7% yield). The solid was 
dissolved in a solution of THF and benzene (6 mL, 1:1) then concentrated to 1.5 mL and 
stored at −40 °C for three days to provide dark green crystals. 1H NMR (500 MHz, C6D6, 
25 °C): δ 19.5 (6H, α-methyl), 8.7 (8H, m-aryl), 4.4 (24H, o-aryl), 3.9 (4H, p-aryl), −0.4 
ppm (12H, β-methyl). UV-vis (CH2Cl2, nm, ε in mM−1cm−1): 435 (6.1), 556 (6.9). 
Mössbauer (80 K, mm/s): δ = 0.28, |ΔEQ| = 1.14. Anal. Calcd for C44H54Fe2N4S2: C, 64.86, 
H, 6.68, N, 6.88. Found: C, 64.59, H, 6.51, N, 6.78.
Synthesis of K[LFe(μ-S)]2
[LFe(μ-S)]2 (516 mg, 0.633 mmol) was dissolved in THF (40 mL) to form a purple solution 
and cooled to −40 °C. Potassium graphite (94.2 mg, 0.697 mmol, 1.10 equiv) was added as a 
solid to the stirring solution, turning the purple solution a dark brown-green color. The 
reaction mixture was stirred at ambient temperature for 30 min and then filtered through 
Celite. The dark red filtrate was concentrated to 25 mL and cooled to −40 °C to yield 
crystals (409 mg, 0.479 mmol, 76%). 1H NMR: silent. UV-vis (CH2Cl2, nm, ε in 
mM−1cm−1): 333 (>15.6), 417 (1.7), 549 (1.2). Mössbauer (80 K, mm/s): δ1 = 0.46, |ΔEQ1| = 
0.85; δ2 = 0.73, |ΔEQ2| = 1.98. Anal. Calcd for C44H54Fe2N4S2K: C, 61.89, H, 6.37, N, 
6.56. Found: C, 61.86, H, 6.21, N, 6.40.
Synthesis of [Kcrypt][LFe(μ-S)]2
K[LFe(μ-S)]2 (207 mg, 0.242 mmol) was dissolved in THF (40 mL) and a solution of 
cryptand-2.2.2 (91.1 mg, 0.242 mmol) in THF (10 mL) was added. The solution was stirred 
for 1.5 h, and then filtered through Celite. The dark red filtrate was concentrated to 40 mL 
and cooled to −40 °C to yield crystals (192 mg, 0.156 mmol, 64%). 1H NMR: silent. UV-vis 
(CH2Cl2, nm, ε in mM−1cm−1): 343 (>18.8), 448 (2.9), 556 (1.9). Mössbauer (80 K, mm/s) 
δ1 = 0.56, |ΔEQ1| = 1.02; δ2 = 0.75, |ΔEQ2| = 1.92. Anal. Calcd for C62H90N6Fe2S2KO6: C, 
60.53, H, 7.37, N, 6.89. Found: C, 60.60, H, 7.36, N, 6.79.
Synthesis of [((C6H5)3P)2N][LFe(μ-S)]2
[LFe(μ-S)]2 (36.6 mg, 0.0449 mmol) was dissolved in THF (3 mL) to form a purple 
solution. Potassium graphite (7.9 mg, 0.058 mmol, 1.3 equiv) was added as a solid to the 
stirring solution, turning the purple solution a dark brown-green color. The reaction mixture 
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was stirred at ambient temperature for 30 min and then filtered through Celite. The filtrate 
was a dark red-purple color. To the stirring solution, PPNCl (25.8 mg, 0.045 mmol, 1.0 
equiv) was added as a solid. The reaction mixture was stirred at ambient temperature for 30 
min then filtered through Celite. The volatile materials were removed under reduced 
pressure to give a dark red-purple solid (35.0 mg, 0.0259 mmol, 56% yield). 1H NMR: 
silent. UV-vis (CH2Cl2, nm, ε in mM−1cm−1): 336 (>12.5), 447 (2.7), 556 (0.52). Mössbauer 
(80 K, mm/s) δ1 = 0.48, |ΔEQ1| = 1.02; δ2 = 0.68, |ΔEQ2| = 1.90. Anal. Calcd for 
C80H54Fe2N5S2P2: C, 71.00, H, 6.26, N, 5.17. Found: C, 71.72, H, 6.46, N, 4.80.
Spectroscopic techniques
1H NMR data were obtained using a Bruker Avance 400 MHz spectrometer at room 
temperature. All resonances (δ) are reported in ppm, relative to residual protiated solvent in 
C6D6 (δ 7.16 ppm). Resonances were singlets unless otherwise noted. Infrared data were 
obtained using a Bruker ALPHA FTIR spectrometer with a platinum ATR attachment inside 
a N2-filled glovebox. Samples were in the solid phase, and crystalline samples were ground 
to ensure uniformity. UV-vis data were collected on an Agilent Technologies Cary 60 UV-
Vis spectrophotomer using Schlenk-adapted quartz cuvettes with a 1 mm optical path length. 
UV-VIS-NIR data were collected on an Agilent Technologies Cary 5000 spectrophotomer 
using quartz cuvettes with 1 cm optical path length. Elemental analyses were obtained from 
the CENTC Elemental Analysis Facility at the University of Rochester. Samples were 
handled in a VAC Atmospheres glovebox under argon and microanalysis samples were 
weighed with a PerkinElmer Model AD-6 Autobalance and their compositions were 
determined with a PerkinElmer 2400 Series II Analyzer.
Mössbauer spectra were recorded on a SeeCo Mössbauer spectrometer with alternating 
constant acceleration. Shifts are relative to iron metal at 298 K. Sample temperature was 
maintained at 80 K with a Janis Research Company Inc. cryostat. The spectrum was 
simulated and fit using WMoss (SeeCo) with Lorentzian doublets.
Electron paramagnetic resonance (EPR) data were obtained using a continuous-wave Bruker 
EleXsys E500 EPR Spectrometer with an SHQ resonator and an Oxford Instruments 
ESR-900 helium-flow cryostat. Acquisition parameters were as follows: frequency = 9.3865 
GHz, power = 0.0020 mW, conversion time = 41 ms, modulation amplitude = 20 G, 
modulation frequency = 100 kHz, time constant = 41 ms. The signal was simulated using 
ESIM (E. Bill, Max Planck Institute for Chemical Energy Conversion, Mülheim an der Ruhr, 
Germany).
Cyclic voltammetry data were recorded using a PINE WaveNow potentiostat inside a N2-
filled glovebox. A Pt ceramic patterned electrode was used as the working and counter 
electrode. A silver electrode was used as a quasireference. The electrolyte was a 2.0 mM 
solution of tetrabutylammonium hexafluorophosphate in dry acetonitrile. A scan rate of 100 
mV/s was used unless otherwise noted. Potentials were referenced to the Cp2Fe+/Cp2Fe 
couple using an internal ferrocene standard.
Crystallographic details are given in the Supporting Information. The crystal structures have 
been deposited in the CCDC with accession numbers 1060312-1060314.
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[LFe(μ-Cl)]2, a previously characterized diiron(II) complex [33], reacts with KC8 at −108 °C 
to form an iron(I) solution, and addition of S8 at this low temperature gives the diferric 
species [LFe(μ-S)]2 (Scheme 1). This is the same reduction method that results in the 
activation of N2 if the reduced solution is warmed [34], but the transient iron(I) intermediate 
can be trapped using elemental sulfur. The oxidation of an iron(I) species with S8 was very 
recently reported by Fohlmeister et al., which also gave a neutral Fe2(μ-S)2 cluster [32]. 
Synthesis of [LFe(μ-S)]2 can also be accomplished through the addition of elemental sulfur 
to [LFe(benzene)], a previously characterized iron(I) complex [35], but this reaction does 
not go cleanly, making isolation through this method difficult.
The molecular structure of [LFe(μ-S)]2 from X-ray crystallography shows a diamond core 
with tetrahedral iron atoms (Figure 2). The core bond lengths and angles (Table 1) are 
similar to those reported for other synthetic [2Fe-2S] clusters [24,32,36,37], and biological 
[2Fe-2S] clusters [8, 38].
Reducing the complex by one electron using KC8 gives the new mixed valent [2Fe-2S] 
cluster K(THF)4[LFe(μ-S)]2. We were able to grow single crystals of this compound and of 
K(cryptand-2.2.2)[LFe(μ-S)]2 (Figure 2). The best stability for spectroscopic studies comes 
from cation exchange to give PPN[LFe(μ-S)]2 (Scheme 2). All mixed valent clusters are 1H 
NMR silent. We attribute this to fast relaxation of the protons due to paramagnetism.
The zero field Mössbauer spectrum of [LFe(μ-S)]2 fits to one quadrupole doublet with δ = 
0.28 mm/s and |ΔEQ| = 1.14 mm/s (Figure 3). These values agree with reported values for 
synthetic diferric [2Fe-2S] clusters [16–19,24–27]. Typical values for nitrogen ligated 
clusters are δ = 0.24 – 0.28 mm/s and |ΔEQ| = 0.87 – 1.26 mm/s. In Rieske clusters, the N-
ligated iron has a slightly larger isomer shift of δ = 0.32 mm/s [39,40].
Two quadrupole doublets are observed in the Mössbauer spectrum of PPN[LFe(μ-S)]2 (δ = 
0.48 mm/s and |ΔEQ| = 1.02 mm/s; δ = 0.68 mm/s and |ΔEQ| = 1.90 mm/s) (Figure 3), 
suggesting two different iron environments, and thus the valence is not fully delocalized on 
the Mössbauer timescale. The isomer shifts in PPN[LFe(μ-S)]2 differ by 0.20 mm/s, which 
suggests partial delocalization of the unpaired electron (Robin-Day Class II) [19,36,41,42]. 
K(THF)4[LFe(μ-S)]2 (Figure S1) has slightly more localization with a difference in isomer 
shift of 0.25 mm/s. This may be attributable to the coordination of the cation to the [FeS] 
core. The difference in isomer shift for [Kcrypt][LFe(μ-S)]2 is similar to the PPN analogue, 
as would be expected with Δδ = 0.19 mm/s (Figure S2). The Mössbauer spectrum of 
K(crypt)[LFe(μ-S)]2 does not change upon increasing the temperature from 80 K to 200 K 
(Figure S2). The Mössbauer parameters are compared to other synthetic [16–19, 24–27] and 
biological [37–39] [2Fe-2S] clusters in Table 2.
Alternative fits can be found in the SI for K[LFe(μ-S)]2 (Figure S1) and K(crypt)[LFe(μ-S)]2 
(Figure S2). The alternative fit for PPN[LFe(μ-S)]2 has one iron site with δ = 0.34 mm/s and 
|ΔEQ| = 1.22 mm/s, and one with δ = 0.81 mm/s and |ΔEQ| = 1.62 mm/s. This fit with Δδ = 
0.47 mm/s is further from literature precedents (see above), and inconsistent with the partial 
delocalization observed by EPR spectroscopy (see below).
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At 9.8 K, the X-band EPR spectrum of PPN[LFe(μ-S)]2 (Figure 3) consists of one nearly 
axial S = ½ signal with g = [2.015, 1.921, 1.904] and gav = 1.946. Rieske proteins have gav = 
1.90 – 1.91 that are smaller than their symmetrical counterparts, ferredoxins (1.95 – 1.97) 
[39,43,44], due to the localization of the unpaired electron on one of the iron atoms in the 
asymmetric cluster. Ferredoxins, which have delocalized valence in the Fe2+Fe3+ form, have 
gav closer to the value of the free electron. The average g-factor of PPN[LFe(μ-S)]2 lies 
between these values, consistent with partial delocalization like other synthetic mixed valent 
complexes [16–19,24–27]. As in other isolable synthetic mixed-valence [2Fe-2S] 
compounds, we observe no intervalence charge-transfer band via UV-Vis-NIR spectroscopy 
(Figure S7) [16–19,24–27].
The crystal structure of K(crypt)[LFe(μ-S)]2 shows two crystallographically independent 
molecules. In a key observation, one iron atom has Fe-S bonds that are shorter by ~0.04 Å 
and Fe-N bonds that are shorter by ~0.02 Å (Table 1), consistent with this site being the 
more oxidized iron(III) site. Localization of iron sites was previously observed in a 
[2Fe-2S]+ cluster with two different supporting ligands [27], where the bonds from sulfide to 
the N-coordinated iron (FeN) were about 0.08 Å longer than those to the S-coordinated iron 
(FeS). This is twice the difference observed in K(crypt)[LFe(μ-S)]2. However, it is more 
relevant to consider the two previous mixed-valence [2Fe-2S] clusters with identical 
supporting ligands on each iron center [17,24]. In the first the molecule was found on a 
crystallographic inversion center, which makes it impossible for the crystal structure to show 
asymmetry between the iron sites [17]. This phenomenon could mask any asymmetry of the 
core through static disorder, an idea that was supported in the crystal structure of a very 
similar compound in which the subsites were crystallographically independent [24], in 
which the bonds from the bridging sulfides were 0.02–0.03 Å longer to one of the two iron 
atoms, and the same iron atom also had longer bonds to the supporting ligand.
Interestingly, the two crystal structures of the diketiminate complexes show both situations. 
The X-ray crystal structure of K(THF)4[LFe(μ-S)]2 has the Fe2S2 rhomb lying on a 
crystallographic inversion center, and necessarily shows equivalent bond distances to the two 
Fe atoms. However, the crystal structure of the K(crypt) salt has crystallographically 
independent iron sites, enabling us to distinguish the iron(II) site with the longer bonds from 
the iron(III) site with the shorter bonds. The crystallographic observation of localization is 
consistent with the observation of two different doublets in the Mössbauer spectrum. We 
note in passing that the observation of site localization by X-ray and Mössbauer 
spectroscopies indicates that the reason for the overall S = 1/2 ground state of the cluster 
(rather than the S = 9/2 ground state that might be expected with strong double exchange 
[45,46]) is charge localization, rather than vibronic coupling as previously proposed [47].
Solutions of the new clusters in acetonitrile show a reversible Fe3+2/Fe2+Fe3+ couple at 
−1.00 V vs. Cp2Fe+/Cp2Fe (Figure 4). This redox potential is much closer to biological 
clusters [48] than other reported synthetic [2Fe-2S] clusters [16–19,24–27] (Table 3). We 
attribute the relatively positive potential to the fact that [LFe(μ-S)]2 is not anionic like the 
other synthetic clusters, while the biological clusters have hydrogen bonding to the 
coordinated thiolates that dissipates negative charge buildup [49]. The only previously 
published neutral clusters gave irreversible reductions [28,32].
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The diferrous state has been observed in a few ferredoxin [52,53] and Rieske [54,55] 
[2Fe-2S] clusters. This doubly reduced cluster can be stabilized in proteins by protonation or 
hydrogen bonding to nearby residues [56]. We observe a second quasi-reversible redox event 
at a more negative potential of −1.36 V. This redox event is tentatively assigned as a 
Fe2+Fe3+/Fe2+2 couple; however, we were unable to isolate the diferrous cluster. Recently, 
Albers et al. reported the first and only synthetic diferrous [2Fe-2S] cluster [57].
Conclusion
We have discovered a route to [2Fe-2S] clusters from S8 oxidation of a transient iron(I) 
species, which opens the door to diketiminate-supported [2Fe-2S] clusters. The single 
negative charge on the bidentate diketiminate is less than the two negative charges from 
typical bis(thiolate) or bis(benzimidazole) supporting ligands, and the less negative redox 
potential makes these clusters easier to handle and study. The spectroscopic characteristics 
of the mixed-valence Fe3+Fe2+ cluster indicate that the electron is only partially delocalized, 
with spectroscopically and crystallographically distinguishable iron(II) vs. iron(III) sites in 
the ground state. These results suggest that previous observations of symmetric cores were 
caused by crystal packing constraints, and that there is site localization in agreement with 
Mössbauer data.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Core structures of (a) ferredoxin, (b) Rieske type, (c) MitoNEET and (d) [LFe(μ-S)]2 
[2Fe-2S] clusters.
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Plot of [LFe(μ-S)]2 (top left), K(THF)4[LFe(μ-S)]2 (top right), and K(cryptand-2.2.2)
[LFe(μ-S)]2 (bottom) with thermal ellipsoids at 50% probability. Hydrogen atoms, solvent, 
and second molecule in K(cryptand-2.2.2)[LFe(μ-S)]2 unit cell omitted for clarity.
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Left: The zero field Mössbauer spectra of (top) diferric [LFe(μ-S)]2 in the solid state at 80 K, 
and (bottom) mixed-valent PPN[LFe(μ-S)]2 as a frozen solution in THF at 80 K. The black 
circles are the data and the purple lines represent the simulated fits. Right: The derivative X-
band EPR spectrum of mixed valent PPN[LFe(μ-S)]2 as a 0.2 mM solution in THF at 9.8 K.
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Cyclic voltammogram of 2.08 mM [LFe(μ-S)]2 in acetonitrile with 0.16 M NBu4PF6, with a 
scan rate of 100 mV/s referenced to ferrocene using an internal standard (not shown).
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Synthesis of [LFe(μ-S)]2 from [LFe(μ-Cl)]2
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Table 3
Redox potentials for [2Fe-2S] clusters
Oxidized Cluster Fe3+2/Fe3+Fe2+ (V)a Fe3+Fe2+/Fe2+2 (V)a Ref
[LFe(μ-S)]2 −1.00 −1.36 This work
[N2Fe(μ-S)]2−2 −1.23 −2.20 17
[N2Fe(μ-S)]2−2 −1.43 −2.19 27
[N2Fe(μ-S)2FeS2]−2 −2.38 - 16
[N2Fe(μ-S)2FeS2]−2 −1.21 −2.17 25
Protein type Fe3+2/Fe3+Fe2+ (V)b Ref
Ferredoxin −0.85 to −0.65 48
Rieske −0.56 to −0.04 49
*
For entries 2–5, N2 = bis(benzimidazolate) ligand; for entries 4 and 5, S2 = 1,1′-biphenyl 2,2-dithiolate ligand
a
All reduction potentials referenced to [FeCp2]0/+. Entry 4 is referenced to [FeCp2*]0/+ and converted with E° = −0.48 V vs [FeCp2]0/+ in 
acetonitrile [50].
b
Protein values referenced to [FeCp2]0/+ using E° = +0.40 V. vs. SHE in water [51]. SHE = standard hydrogen electrode.
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